Form 4: Intra-Cellular Therapies Director Joel S. Marcus Executes Stock Options and Sells Shares

Director Joel S. Marcus exercised stock options and sold shares of Intra-Cellular Therapies on February 26, 2024.

Summary

• On February 26, 2024, Joel S. Marcus, a director of Intra-Cellular Therapies, Inc., engaged in multiple transactions involving the company's common stock.
• Marcus exercised stock options to acquire 20,000 shares at $43.45 and 16,757 shares at $55.48.
• He then sold 8,371 shares at a weighted average price of $67.83, 17,658 shares at a weighted average price of $69.07, and 299 shares at a weighted average price of $69.60.
• Following these transactions, Marcus directly owns 39,662 shares and indirectly owns 10,000 shares through Alexandria Real Estate Equities, Inc.
• All shares underlying the stock options exercised have vested.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the director's stock sales, but the overall effect is likely minimal given the volume traded relative to the company's total outstanding shares.

Key Dates